Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Albera
Prs1 - Real-World Evaluation of the Effectiveness and Safety of Pirfenidone: Findings From an Observational Chart Review of a Large Cohort of Idiopathic Pulmonary Fibrosis (Ipf) Patients in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Activated and Memory Alveolar T-Lymphocytes in Idiopathic Eosinophilic Pneumonia
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Related publications
Idiopathic Pulmonary Fibrosis and Pirfenidone
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis
Internal Medicine
Internal Medicine
Medicine
Analysis of Patients With Idiopathic Pulmonary Fibrosis (IPF) With More Severe Lung Function Impairment Treated With Pirfenidone in Recap
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
A 2-Year Observational Study in Patients Suffering From Idiopathic Pulmonary Fibrosis and Treated With Pirfenidone: A French Ancillary Study of PASSPORT
Respiration
Pulmonary
Respiratory Medicine
Comparison of the Antifibrotic Effects of the Pan-Histone Deacetylase-Inhibitor Panobinostat Versus the IPF-drug Pirfenidone in Fibroblasts From Patients With Idiopathic Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
Prs58 - Patients With Idiopathic Pulmonary Fibrosis (Ipf): What Happens Before the Diagnosis? A Real-World, Retrospective, Primary Care Database Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
Advances in Therapy
Medicine
Pharmacology
Pathogenesis of Idiopathic Pulmonary Fibrosis: Review of Recent Findings
F1000Prime Reports
Prs41 - Cost-Effectiveness of Pirfenidone for the Treatment of Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
